Novartis to manufacture partner’s COVID-19 vaccine ‘at no cost’
Massachusetts General Hospital readies its vaccine for clinical trials by signing manufacturing agreement with Novartis.
Massachusetts General Hospital readies its vaccine for clinical trials by signing manufacturing agreement with Novartis.
Oxford Biomedica signs on to produce clinical and commercial supply of AZD1222, which recently entered late-stage trials.